Your browser doesn't support javascript.
loading
Third COVID-19 vaccine dose with BNT162b2 in patients with ANCA-associated vasculitis.
Speer, Claudius; Töllner, Maximilian; Benning, Louise; Klein, Katrin; Bartenschlager, Marie; Nusshag, Christian; Kälble, Florian; Reichel, Paula; Schnitzler, Paul; Zeier, Martin; Morath, Christian; Schmitt, Wilhelm H; Bergner, Raoul; Bartenschlager, Ralf; Schaier, Matthias.
Afiliación
  • Speer C; Nephrology, University Hospital Heidelberg, Heidelberg, Germany claudius.speer@med.uni-heidelberg.de.
  • Töllner M; Molecular Medicine Partnership Unit Heidelberg, European Molecular Biology Laboratory, Heidelberg, Baden-Württemberg, Germany.
  • Benning L; Nephrology, University Hospital Heidelberg, Heidelberg, Germany.
  • Klein K; Nephrology, University Hospital Heidelberg, Heidelberg, Germany.
  • Bartenschlager M; Nephrology, University Hospital Heidelberg, Heidelberg, Germany.
  • Nusshag C; Department of Infectious Diseases, Virology Heidelberg, Heidelberg, Germany.
  • Kälble F; Nephrology, University Hospital Heidelberg, Heidelberg, Germany.
  • Reichel P; Nephrology, University Hospital Heidelberg, Heidelberg, Germany.
  • Schnitzler P; Nephrology, University Hospital Heidelberg, Heidelberg, Germany.
  • Zeier M; Department of Infectious Diseases, Virology Heidelberg, Heidelberg, Germany.
  • Morath C; Nephrology, University Hospital Heidelberg, Heidelberg, Germany.
  • Schmitt WH; Nephrology, University Hospital Heidelberg, Heidelberg, Germany.
  • Bergner R; Department of Nephrology and Rheumatology, Kidney Center Weinheim, Weinheim, Germany.
  • Bartenschlager R; Department of Internal Medicine A, Clinical Center Ludwigshafen, Ludwigshafen, Germany.
  • Schaier M; Department of Infectious Diseases, Virology Heidelberg, Heidelberg, Germany.
Ann Rheum Dis ; 81(4): 593-595, 2022 04.
Article en En | MEDLINE | ID: mdl-35012926

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Terapia de Inmunosupresión / Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos / SARS-CoV-2 / COVID-19 / Vacuna BNT162 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Terapia de Inmunosupresión / Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos / SARS-CoV-2 / COVID-19 / Vacuna BNT162 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2022 Tipo del documento: Article País de afiliación: Alemania